secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001798749-24-000003
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate furnishes corporate presentation with no new material facts disclosed
------------------------------------------------------------------------------

- Corporate presentation filed as Exhibit 99.1; no updated financial or clinical data provided.
- Presentation reiterates focus on AV-101 for pulmonary arterial hypertension.
- Filing is routine Regulation FD disclosure; no guidance or milestone changes announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000003/0001798749-24-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000003/tmb-20240108x8k.htm
  HTML page:      https://secwatch.observer/filing/0001798749-24-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer